306 related articles for article (PubMed ID: 23109406)
1. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study.
Ndumele CE; Matsushita K; Astor B; Virani SS; Mora S; Williams EK; Hoogeveen RC; Blumenthal RS; Sharrett AR; Ballantyne CM; Coresh J
Eur J Prev Cardiol; 2014 Jul; 21(7):866-75. PubMed ID: 23109406
[TBL] [Abstract][Full Text] [Related]
2. Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study.
Lamprea-Montealegre JA; Sharrett AR; Matsushita K; Selvin E; Szklo M; Astor BC
Atherosclerosis; 2014 May; 234(1):42-6. PubMed ID: 24607852
[TBL] [Abstract][Full Text] [Related]
3. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
[TBL] [Abstract][Full Text] [Related]
4. Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL).
Holme I; Strandberg TE; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Larsen ML; Lindahl C; Pedersen TR;
Atherosclerosis; 2009 Aug; 205(2):522-7. PubMed ID: 19327776
[TBL] [Abstract][Full Text] [Related]
5. Use of lipoprotein particle measures for assessing coronary heart disease risk post-American Heart Association/American College of Cardiology guidelines: the Multi-Ethnic Study of Atherosclerosis.
Steffen BT; Guan W; Remaley AT; Paramsothy P; Heckbert SR; McClelland RL; Greenland P; Michos ED; Tsai MY
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):448-54. PubMed ID: 25477346
[TBL] [Abstract][Full Text] [Related]
6. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.
Sharrett AR; Ballantyne CM; Coady SA; Heiss G; Sorlie PD; Catellier D; Patsch W;
Circulation; 2001 Sep; 104(10):1108-13. PubMed ID: 11535564
[TBL] [Abstract][Full Text] [Related]
7. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
Pischon T; Girman CJ; Sacks FM; Rifai N; Stampfer MJ; Rimm EB
Circulation; 2005 Nov; 112(22):3375-83. PubMed ID: 16316964
[TBL] [Abstract][Full Text] [Related]
8. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
[TBL] [Abstract][Full Text] [Related]
9. Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease.
Pan L; Lu G; Chen Z
Coron Artery Dis; 2014 Aug; 25(5):433-8. PubMed ID: 24608795
[TBL] [Abstract][Full Text] [Related]
10. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
[TBL] [Abstract][Full Text] [Related]
11. Non-high-density lipoprotein cholesterol changes in middle-aged obese men with and without metabolic syndrome during weight loss.
Kim M; Tanaka K
Metab Syndr Relat Disord; 2014 Nov; 12(9):464-71. PubMed ID: 25247924
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men.
Wallenfeldt K; Bokemark L; Wikstrand J; Hulthe J; Fagerberg B
Stroke; 2004 Oct; 35(10):2248-52. PubMed ID: 15345795
[TBL] [Abstract][Full Text] [Related]
13. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population.
Sierra-Johnson J; Fisher RM; Romero-Corral A; Somers VK; Lopez-Jimenez F; Ohrvik J; Walldius G; Hellenius ML; Hamsten A
Eur Heart J; 2009 Mar; 30(6):710-7. PubMed ID: 18676970
[TBL] [Abstract][Full Text] [Related]
14. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.
Ridker PM; Rifai N; Cook NR; Bradwin G; Buring JE
JAMA; 2005 Jul; 294(3):326-33. PubMed ID: 16030277
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
[TBL] [Abstract][Full Text] [Related]
17. Serum total and high-density lipoprotein phospholipids: independent predictive value for cardiometabolic risk.
Onat A; Altuğ Çakmak H; Can G; Yüksel M; Köroğlu B; Yüksel H
Clin Nutr; 2014 Oct; 33(5):815-22. PubMed ID: 24246837
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
19. Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis.
Honda H; Hirano T; Ueda M; Kojima S; Mashiba S; Hayase Y; Michihata T; Shishido K; Takahashi K; Hosaka N; Ikeda M; Sanada D; Shibata T
PLoS One; 2017; 12(5):e0177980. PubMed ID: 28542510
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study.
Sattar N; Williams K; Sniderman AD; D'Agostino R; Haffner SM
Circulation; 2004 Oct; 110(17):2687-93. PubMed ID: 15492304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
